Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | C1R | P00736 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.49 |
| ▸ | ELANE | P08246 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13701106 | 0.88 | ELANE (0.60) | NPC1RAB9AC1RALDH1A1KDM4E | |
| SCHEMBL13701083 | 0.86 | ELANE (0.53) | NPC1RAB9AALDH1A1KDM4EKMT2A | |
| SCHEMBL13701080 | 0.86 | MAPT (0.50) | NPC1RAB9AALDH1A1KDM4EKMT2A | |
| SCHEMBL13701127 | 0.83 | ELANE (0.55) | NPC1RAB9AC1RALDH1A1KDM4E | |
| SCHEMBL13701094 | 0.83 | ELANE (0.57) | NPC1RAB9AC1RALDH1A1KDM4E | |
| SCHEMBL13701117 | 0.82 | ELANE (0.46) | NPC1RAB9AALDH1A1KDM4EKMT2A | |
| SCHEMBL13701085 | 0.82 | MEN1 (0.57) | NPC1C1RALDH1A1KDM4EKMT2A | |
| SCHEMBL13701081 | 0.80 | APEX1 (0.55) | NPC1RAB9AC1RALDH1A1KDM4E | |
| SCHEMBL913895 | 0.78 | NPC1 (0.70) | NPC1RAB9AC1RALDH1A1KDM4E | |
| SCHEMBL13701093 | 0.78 | ELANE (0.40) | NPC1RAB9AC1RALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090239982-A1 | Ultraviolet Absorbent and Heterocyclic Compound | FUJIFILM CORPORATION (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20090239982-A1 | Ultraviolet Absorbent and Heterocyclic Compound | FUJIFILM CORPORATION (JP) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239982-A1 | Ultraviolet Absorbent and Heterocyclic Compound | CYP2A6, CYP2B6, XPO6 | NPC1 1604/4885RAB9A 2997/4885C1R 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.